What is the current stock price of CONMED Corporation (CNMD)?

As of the latest market data, CONMED Corporation (CNMD) is trading at $35.48. The stock has seen a loss of -1.61% today.

Does CONMED Corporation (CNMD) pay a dividend?

Based on current data, CONMED Corporation does not have a confirmed active dividend policy.

What is the market cap of CONMED Corporation?

The current market capitalization of CONMED Corporation (CNMD) is approximately unavailable.

CNMD

CONMED Corporation·Healthcare

35.48

1.608%(−0.58)

Close Price

44.32

24.915%(+8.84)

Pre-Market

Last Updated: — ET

52W L: $33.2152W H: $60.35

CNMD NEWS

zacks.com

2d ago

Can CAH's Surging Other Growth Businesses Become Its Next Profit Engine?

CAH's fast-growing Other Growth Businesses posted 34% revenue growth and 52% profit gains, raising their role in long-term earnings.

gurufocus.com

May 20

CONMED Corporation Appoints Celine Martin and Jeff Mirviss to its Board of Directors

CONMED Corporation (NYSE: CNMD) today announced the appointment of Celine Martin and Jeff Mirviss to its Board of Directors (âBoardâ), effective July 1, 20

businesswire.com

May 20

CONMED Corporation Appoints Celine Martin and Jeff Mirviss to its Board of Directors

LARGO, Fla.--(BUSINESS WIRE)--CONMED Corporation (NYSE: CNMD) today announced the appointment of Celine Martin and Jeff Mirviss to its Board of Directors (“Board”), effective July 1, 2026. Ms. Martin will serve as a member of the Audit Committee and the Strategy Committee, and Mr. Mirviss will serve as a member of the Compensation Committee and the Corporate Governance and Nominating Committee. In connection with these appointments, CONMED is increasing the size of its Board to include a total.

zacks.com

May 14

Is the Options Market Predicting a Spike in CONMED Stock?

Investors need to pay close attention to CNMD stock based on the movements in the options market lately.

zacks.com

Apr 30

CONMED's Q1 Earnings and Revenues Beat, Organic Sales Outlook Up

CNMD tops Q1 estimates despite sales dip, lifts 2026 organic growth outlook as strategic shift sharpens focus on higher-growth segments.

seekingalpha.com

Apr 30

CONMED Corporation (CNMD) Q1 2026 Earnings Call Transcript

Company Profile

CONMED Corporation, a medical technology company, develops, manufactures, and sells surgical devices and related equipment for surgical procedures worldwide. It offers orthopedic surgery products, including TruShot with Y-Knot All-In-One Soft Tissue Fixation System, Y-knot All-Suture Anchors, and PopLok Knotless Suture Anchors, which provide unique clinical solutions to orthopedic surgeons for the repair of soft tissue injuries, as well as supporting products that enable surgeons to perform minimally invasive sports medicine surgeries. The company markets orthopedic surgery products under the Hall, CONMED Linvatec, Concept, and Shutt brands. It also offers general surgery products, such as clinical insufflation, smoke evacuation, electrosurgical, and endomechanical products; and endoscopic technologies, including diagnostic and therapeutic products for use in gastroenterology procedures, and products for the treatment of diseases of the biliary structures, as well as cardiac monitoring products comprising ECG and EEG electrodes, and cardiac defibrillation pads. The company markets its products directly to hospitals, surgery centers, and other healthcare institutions, as well as through medical specialty distributors. CONMED Corporation was incorporated in 1970 and is headquartered in Largo, Florida.

Sector

Healthcare

Industry

Medical - Devices

Employees

3,900

IPO Date

1987-07-23

Beta

0.94

Websitewww.conmed.com↗